Financial results - FARMACIA SÎRBU SRL

Financial Summary - Farmacia Sîrbu Srl
Unique identification code: 32391900
Registration number: J35/2679/2013
Nace: 4773
Sales - Ron
64.201
Net Profit - Ron
55.596
Employee
3
The most important financial indicators for the company Farmacia Sîrbu Srl - Unique Identification Number 32391900: sales in 2023 was 64.201 euro, registering a net profit of 55.596 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Farmacia Sîrbu Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 16.510 23.290 42.902 38.664 28.700 26.522 56.491 36.762 52.271 64.201
Total Income - EUR 16.683 23.978 42.902 38.858 28.701 26.522 56.491 36.766 52.271 91.148
Total Expenses - EUR 21.580 28.260 43.723 40.783 20.412 19.085 50.121 91.150 68.103 34.730
Gross Profit/Loss - EUR -4.897 -4.282 -821 -1.926 8.289 7.437 6.371 -54.385 -15.831 56.418
Net Profit/Loss - EUR -5.398 -5.001 -1.250 -2.314 8.090 7.172 5.806 -54.752 -16.353 55.596
Employees 2 2 2 2 2 0 2 2 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 23.2%, from 52.271 euro in the year 2022, to 64.201 euro in 2023. The Net Profit increased by 55.596 euro, from 0 euro in 2022, to 55.596 in the last year.

Check the financial reports for the company - Farmacia Sîrbu Srl

Rating financiar

Financial Rating -
Farmacia Sîrbu Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Farmacia Sîrbu Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Farmacia Sîrbu Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Farmacia Sîrbu Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Farmacia Sîrbu Srl - CUI 32391900

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 124 823 392 267 204 200 0 0 0 0
Current Assets 6.098 8.113 7.498 5.709 19.476 40.807 55.257 11.068 6.018 58.397
Inventories 4.232 6.057 4.647 3.141 16.663 36.864 51.888 9.213 910 51.919
Receivables 979 1.820 1.713 2.563 2.621 3.579 2.451 1.763 4.254 6.216
Cash 887 236 1.138 5 191 364 918 93 854 263
Shareholders Funds -6.043 -11.094 -12.232 -14.338 -5.942 1.345 7.126 -47.785 -64.286 -8.495
Social Capital 45 45 45 44 86 84 83 81 81 81
Debts 12.265 20.030 20.122 20.314 25.622 39.662 48.132 58.853 70.304 66.893
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 58.397 euro in 2023 which includes Inventories of 51.919 euro, Receivables of 6.216 euro and cash availability of 263 euro.
The company's Equity was valued at -8.495 euro, while total Liabilities amounted to 66.893 euro. Equity increased by 55.596 euro, from -64.286 euro in 2022, to -8.495 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Farmacia Sîrbu Srl

Comments - Farmacia Sîrbu Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.